Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aubrey Galloway

Thoracic Surgery (Cardiothoracic Vascular Surgery) New York, NY Medical Doctor

NPI 1982696696 CMS profile 90444

530 1St Ave, Suite 9V, New York, NY 10016

Open in the dashboard

General payments

$5,726,916

129 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$12,091 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Aubrey Galloway of New York, NY is reported in the CMS Open Payments database as having received $5,726,916 across 129 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $12,091 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $425,239 18
2024 General $412,955 18
2023 General $557,769 17
2022 General $1,127,733 16
2021 General $1,134,256 14
2020 General $981,926 15
2019 General $1,087,037 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aubrey Galloway
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Aubrey Galloway were reported at $425,239. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Aubrey Galloway Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $1,087,037 $886 $178–$3,167 $163
2020 $981,926 $341 $108–$1,605 $114
2021 $1,134,256 $453 $125–$1,886 $132
2022 $1,127,733 $695 $180–$2,566 $149
2023 $557,769 $745 $205–$2,662 $160
2024 $412,955 $799 $214–$2,967 $164
2025 $425,239 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $3,656,997 63 payments
  2. Medtronic Vascular, Inc. $2,038,083 42 payments
  3. Edwards Lifesciences Corporation $31,069 7 payments
  4. Abbott Laboratories $268 3 payments
  5. Baxter Healthcare $194 7 payments
  6. Abiomed $167 1 payment
  7. Pfizer Inc. $49 2 payments
  8. Atricure, Inc. $43 2 payments
  9. Kiniksa Pharmaceuticals, Ltd. $24 1 payment
  10. Zimmer Biomet Holdings, Inc. $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $5,708,624 85 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,000 3 payments
  3. Food and Beverage $2,398 37 payments
  4. Travel and Lodging $894 4 payments
Products named General payments · program years 2019–2025
  1. Contour 3D Heart Valves $2,457,362 39 payments
  2. CG Future Heart Valves $1,136,939 20 payments
  3. Contour 3D Heart Valves $1,087,441 15 payments
  4. CG Future Heart Valves $938,267 13 payments
  5. Profile 3D $62,342 1 payment
  6. EDWARDS INTUITY Elite valve system $30,600 1 payment
  7. Avalus Heart Valves $9,119 2 payments
  8. Mosaic $1,190 9 payments
  9. Avalus Heart Valves $354 3 payments
  10. EPIC $244 2 payments
  11. Other $661 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$42,362

Medicare's payments for the services billed

Medicare patients

51

Average age 74

Services billed

80

21 women, 30 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 65%
Arthritis 51%
Atrial fibrillation 37%
Heart failure 31%
COPD 29%
Chronic kidney disease 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record